This is a randomized, controlled, open-label, phase III trials. The main purpose of this study is to evaluate the effectiveness and safety of tumor treating felds (TTF) combined with stereotactic radiosurgery (SRS) in the treatment of brain metastases from non-small cell lung cancer (NSCLC) .
The age of the subject was between 18 and 75 years old (inclusive), regardless of gender;
The predicted survival time was ≥3 months;
Newly diagnosed with NSCLC brain metastasis;
MRI imaging showed 1-10 unresectable brain metastases;
Positive driver genes;
Recurrent brain metastasis of NSCLC;
Suffering from severe cerebral edema;
Leptomeningeal metastases;
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Lead sponsor
Shandong Cancer Hospital and Institute
Collaborator